– Localization of Core Parts and Consumables Supply Chain … Establishment of Local Supply and After-Sales Service System

Curexo Co., Ltd., a medical robotics company led by CEO Lee Jae-jun, announced on the 13th that its Indian subsidiary has obtained a Medical Device Import License (MD-15) from the Central Drugs Standard Control Organization (CDSCO) for its robotic joint surgery system, CUVIS-joint.

"CUVIS-joint" (Photo courtesy of Curexo)



This approval is a mandatory requirement for the importation of medical devices into India and is significant in that it enables the local subsidiary to directly supply the robotic system, as well as related consumables and core components.



With the acquisition of the license, Curexo has established a system under which its Indian subsidiary can directly import and manage consumables and key components, for which demand is increasing in line with the growing number of surgical procedures. This is expected to shorten delivery lead times for consumables in India, enhance inventory responsiveness, and ultimately improve the operational stability and convenience of robotic surgery programs at medical institutions.



In addition, the local subsidiary will serve as a service hub, providing equipment maintenance and technical support to distributors and healthcare institutions.



The company stated that establishing a localized response system that integrates parts supply and technical support will help enhance equipment uptime and customer satisfaction, thereby laying the groundwork for future revenue growth.



A Curexo official commented that the acquisition of the import license is meaningful in that it provides a stable foundation for the Indian subsidiary to carry out local supply and service functions, adding that the company will continue to strengthen its local capabilities to enhance business stability in the Indian market.